Akzo Nobel N.V.

ENXTAM:AKZA Stock Report

Market Cap: €10.2b

Akzo Nobel Balance Sheet Health

Financial Health criteria checks 3/6

Akzo Nobel has a total shareholder equity of €4.9B and total debt of €5.9B, which brings its debt-to-equity ratio to 121.1%. Its total assets and total liabilities are €14.9B and €10.0B respectively. Akzo Nobel's EBIT is €876.0M making its interest coverage ratio 7.1. It has cash and short-term investments of €1.8B.

Key information

121.08%

Debt to equity ratio

€5.89b

Debt

Interest coverage ratio7.1x
Cash€1.77b
Equity€4.86b
Total liabilities€9.99b
Total assets€14.85b

Recent financial health updates

These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Extensively

May 22
These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Extensively

Is Akzo Nobel (AMS:AKZA) A Risky Investment?

Oct 14
Is Akzo Nobel (AMS:AKZA) A Risky Investment?

We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt

Jul 03
We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt

Recent updates

These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Extensively

May 22
These 4 Measures Indicate That Akzo Nobel (AMS:AKZA) Is Using Debt Extensively

Akzo Nobel (AMS:AKZA) Will Pay A Dividend Of €1.54

Apr 18
Akzo Nobel (AMS:AKZA) Will Pay A Dividend Of €1.54

Is Akzo Nobel N.V. (AMS:AKZA) Potentially Undervalued?

Mar 26
Is Akzo Nobel N.V. (AMS:AKZA) Potentially Undervalued?

Why We're Not Concerned About Akzo Nobel N.V.'s (AMS:AKZA) Share Price

Mar 14
Why We're Not Concerned About Akzo Nobel N.V.'s (AMS:AKZA) Share Price

Akzo Nobel (AMS:AKZA) Will Pay A Dividend Of €1.54

Feb 12
Akzo Nobel (AMS:AKZA) Will Pay A Dividend Of €1.54

Is There An Opportunity With Akzo Nobel N.V.'s (AMS:AKZA) 50% Undervaluation?

Jan 27
Is There An Opportunity With Akzo Nobel N.V.'s (AMS:AKZA) 50% Undervaluation?

There's Been No Shortage Of Growth Recently For Akzo Nobel's (AMS:AKZA) Returns On Capital

Jan 13
There's Been No Shortage Of Growth Recently For Akzo Nobel's (AMS:AKZA) Returns On Capital

Why Akzo Nobel N.V. (AMS:AKZA) Could Be Worth Watching

Nov 25
Why Akzo Nobel N.V. (AMS:AKZA) Could Be Worth Watching
author-image

Steady Streamlining And Strategic Expansion Ignite A Brighter Future

Efficiency programs and workforce reductions are set to bolster net margins through significant cost savings.

Is Akzo Nobel (AMS:AKZA) A Risky Investment?

Oct 14
Is Akzo Nobel (AMS:AKZA) A Risky Investment?

Why We're Not Concerned About Akzo Nobel N.V.'s (AMS:AKZA) Share Price

Oct 01
Why We're Not Concerned About Akzo Nobel N.V.'s (AMS:AKZA) Share Price

Akzo Nobel's (AMS:AKZA) Returns On Capital Are Heading Higher

Sep 17
Akzo Nobel's (AMS:AKZA) Returns On Capital Are Heading Higher

What Is Akzo Nobel N.V.'s (AMS:AKZA) Share Price Doing?

Aug 21
What Is Akzo Nobel N.V.'s (AMS:AKZA) Share Price Doing?

Akzo Nobel N.V. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 26
Akzo Nobel N.V. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt

Jul 03
We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt

Akzo Nobel N.V. (AMS:AKZA) Shares Could Be 28% Below Their Intrinsic Value Estimate

Jun 20
Akzo Nobel N.V. (AMS:AKZA) Shares Could Be 28% Below Their Intrinsic Value Estimate

Akzo Nobel (AMS:AKZA) Is Doing The Right Things To Multiply Its Share Price

Jun 06
Akzo Nobel (AMS:AKZA) Is Doing The Right Things To Multiply Its Share Price

Financial Position Analysis

Short Term Liabilities: AKZA's short term assets (€6.5B) exceed its short term liabilities (€4.8B).

Long Term Liabilities: AKZA's short term assets (€6.5B) exceed its long term liabilities (€5.2B).

Debt to Equity History and Analysis

Debt Level: AKZA's net debt to equity ratio (84.6%) is considered high.

Reducing Debt: AKZA's debt to equity ratio has increased from 34.8% to 121.1% over the past 5 years.

Debt Coverage: AKZA's debt is not well covered by operating cash flow (12.4%).

Interest Coverage: AKZA's interest payments on its debt are well covered by EBIT (7.1x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/27 01:04
End of Day Share Price 2025/05/27 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Akzo Nobel N.V. is covered by 55 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mutlu GundoganABN AMRO Bank N.V.
Martin SchneeAlphaValue
Colin IsaacAtlantic Equities LLP